Lantern Pharma Stock (NASDAQ: LTRN) stock price, news, charts, stock research, profile.
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Other companies in Lantern Pharma’s space includes: Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
Lantern Pharma has a consensus price target of $11.00.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $3.9099 last updated October 2, 2024 at 6:21 PM EDT.
There are no upcoming dividends for Lantern Pharma.
Lantern Pharma’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.